[HTML][HTML] Monogenic diabetes: a gateway to precision medicine in diabetes
Monogenic diabetes refers to diabetes mellitus (DM) caused by a mutation in a single gene
and accounts for approximately 1%–5% of diabetes. Correct diagnosis is clinically critical for …
and accounts for approximately 1%–5% of diabetes. Correct diagnosis is clinically critical for …
The challenge of genetic variants of uncertain clinical significance: a narrative review
Genomic tests expand diagnostic and screening opportunities but also identify genetic
variants of uncertain clinical significance (VUSs). Only a minority of VUSs are likely to prove …
variants of uncertain clinical significance (VUSs). Only a minority of VUSs are likely to prove …
[HTML][HTML] Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria
Summary Recommendations from the American College of Medical Genetics and Genomics
and the Association for Molecular Pathology (ACMG/AMP) for interpreting sequence variants …
and the Association for Molecular Pathology (ACMG/AMP) for interpreting sequence variants …
[HTML][HTML] Genome-wide prediction of disease variant effects with a deep protein language model
Predicting the effects of coding variants is a major challenge. While recent deep-learning
models have improved variant effect prediction accuracy, they cannot analyze all coding …
models have improved variant effect prediction accuracy, they cannot analyze all coding …
[HTML][HTML] Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen) …
Purpose Several professional societies have published guidelines for the clinical
interpretation of somatic variants, which specifically address diagnostic, prognostic, and …
interpretation of somatic variants, which specifically address diagnostic, prognostic, and …
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
A Leonetti, M Verzè, R Minari, F Perrone… - British journal of …, 2024 - nature.com
Background Resistance to osimertinib in advanced EGFR-mutated non-small cell lung
cancer (NSCLC) constitutes a significant challenge for clinicians either in terms of molecular …
cancer (NSCLC) constitutes a significant challenge for clinicians either in terms of molecular …
[HTML][HTML] Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation
EJ Radford, HK Tan, MHL Andersson… - Nature …, 2023 - nature.com
Loss-of-function of DDX3X is a leading cause of neurodevelopmental disorders (NDD) in
females. DDX3X is also a somatically mutated cancer driver gene proposed to have tumour …
females. DDX3X is also a somatically mutated cancer driver gene proposed to have tumour …
[HTML][HTML] ClinGen guidance for use of the PP1/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification
LG Biesecker, AB Byrne, SM Harrison… - The American Journal of …, 2024 - cell.com
Summary The 2015 American College of Medical Genetics and Genomics and the
Association for Molecular Pathology variant classification publication established a standard …
Association for Molecular Pathology variant classification publication established a standard …
[HTML][HTML] The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion
R Murphy, K Colclough, TI Pollin, JM Ikle… - Communications …, 2023 - nature.com
Background Monogenic diabetes presents opportunities for precision medicine but is
underdiagnosed. This review systematically assessed the evidence for (1) clinical criteria …
underdiagnosed. This review systematically assessed the evidence for (1) clinical criteria …
Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations
A Garrett, M Durkie, A Callaway, GJ Burghel… - Journal of medical …, 2021 - jmg.bmj.com
Accurate classification of variants in cancer susceptibility genes (CSGs) is key for correct
estimation of cancer risk and management of patients. Consistency in the weighting …
estimation of cancer risk and management of patients. Consistency in the weighting …